In Their Own Words With Growth/Venture-Capital Investors in Healthcare

By Laura Cooper, Brian Gormley and Laura Kreutzer, WSJ Pro Private Equity

Healthcare has long attracted both capital and attention from venture-capital firms, a trend that intensified as a result of the coronavirus pandemic. However, heavy regulation, shifting healthcare priorities and the long time horizons associated with drug development often make investing in this sector a complex business. We asked a handful of venture-capital professionals who invest in healthcare to share their thoughts on the challenges the industry faces, how the pandemic has affected it and what excites them most about the future. Responses have been edited for clarity.